Company / Financials
Pfizer Financials
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableRevenue
$62.6B
FY2025 · -1.6% YoY
Net Income
$7.8B
FY2025 · -3.2% YoY
Profit Margin
12.4%
FY2025 · net income / revenue
ROE
9.0%
FY2025 · return on equity
Total Assets
$208.2B
FY2025
Total Debt
$61.6B
0.71x debt/equity
Equity
$86.5B
FY2025
ROA
3.7%
FY2025 · return on assets
Statement paths
Financial highlights
Key Data Points
- Altman Z-Score 1.09 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Metric history
Revenue HistoryTotal revenue from operations$62.6B-1.6% YoYNet Income HistoryProfit after all expenses and taxes$7.8B-3.2% YoYCost of Revenue HistoryDirect costs of producing goods and services sold$16.1B-10.0% YoYSG&A Expense HistorySelling, general, and administrative expenses$13.8B-6.4% YoYR&D Expense HistoryResearch and development spending$10.4B-3.6% YoYInterest Expense HistoryCost of borrowing and debt obligations$2.7B-13.6% YoYIncome Tax HistoryTotal income tax expense-$266.0M-850.0% YoYEPS (Basic) HistoryBasic earnings per share$0.38-93.2% YoYEPS (Diluted) HistoryDiluted earnings per share including stock options and convertibles$0.37-93.2% YoYShares Outstanding HistoryWeighted average diluted shares outstanding5.7B-0.4% YoY